48
Participants
Start Date
June 18, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Apomorphine Hydrochloride 5mg/ml
Product administered using an external continuous subcutaneous infusion pump.
Sodium chloride 9mg/ml
Product administered using an external continuous subcutaneous infusion pump.
RECRUITING
Centre Hospitalier Neurologique William Lennox, Ottignies-Louvain-la-Neuve
ACTIVE_NOT_RECRUITING
University of Liege, Liège
RECRUITING
Hôpital Valdor - ISoSL, Liège
NOT_YET_RECRUITING
VITHAS, Valencia
Centre Hospitalier Neurologique William Lennox (Belgium)
UNKNOWN
Hôpital Valdor - ISoSL (Belgium)
UNKNOWN
VITHAS hospitales (Spain)
UNKNOWN
University of Liege
OTHER